HCW Biologics Management
Management criteria checks 3/4
HCW Biologics' CEO is Hing Wong, appointed in Apr 2018, has a tenure of 6.75 years. total yearly compensation is $425.88K, comprised of 96.2% salary and 3.8% bonuses, including company stock and options. directly owns 36.04% of the company’s shares, worth $6.42M. The average tenure of the management team and the board of directors is 5.3 years and 3.7 years respectively.
Key information
Hing Wong
Chief executive officer
US$425.9k
Total compensation
| CEO salary percentage | 96.2% |
| CEO tenure | 6.8yrs |
| CEO ownership | 36.0% |
| Management average tenure | 5.3yrs |
| Board average tenure | 3.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$37m |
| Jun 30 2024 | n/a | n/a | -US$38m |
| Mar 31 2024 | n/a | n/a | -US$27m |
| Dec 31 2023 | US$426k | US$410k | -US$25m |
| Sep 30 2023 | n/a | n/a | -US$20m |
| Jun 30 2023 | n/a | n/a | -US$19m |
| Mar 31 2023 | n/a | n/a | -US$18m |
| Dec 31 2022 | US$421k | US$404k | -US$15m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$12m |
| Dec 31 2021 | US$3m | US$374k | -US$13m |
| Sep 30 2021 | n/a | n/a | -US$8m |
| Jun 30 2021 | n/a | n/a | -US$8m |
| Mar 31 2021 | n/a | n/a | -US$8m |
| Dec 31 2020 | US$374k | US$360k | -US$7m |
Compensation vs Market: Hing's total compensation ($USD425.88K) is below average for companies of similar size in the US market ($USD645.01K).
Compensation vs Earnings: Hing's compensation has increased whilst the company is unprofitable.
CEO
Hing Wong (70 yo)
6.8yrs
Tenure
US$425,880
Compensation
Dr. Hing C. Wong, Ph D., Founded HCW Biologics Inc. and has been its Chief Executive Officer and Director since April 2018. He also serves as a Secretary at HCW Biologics Inc. Dr. Wong founded and served a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.8yrs | US$425.88k | 36.04% $ 6.4m | |
| Chief Financial Officer | 5.3yrs | US$300.30k | 3.1% $ 552.8k | |
| Chief Scientific Officer & VP of Clinical Operations | 5.7yrs | US$251.16k | 0.17% $ 31.0k | |
| Vice President of Legal Affairs | 4.6yrs | no data | no data | |
| Senior Vice President of Business Development | 5.3yrs | no data | 0.43% $ 76.1k |
5.3yrs
Average Tenure
69yo
Average Age
Experienced Management: HCWB's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.8yrs | US$425.88k | 36.04% $ 6.4m | |
| Independent Chairman of the Board | 3.7yrs | US$78.61k | 0.60% $ 107.1k | |
| Independent Director | 3.3yrs | US$58.61k | 0.080% $ 14.3k | |
| Independent Director | 3.7yrs | US$68.61k | 0.099% $ 17.7k | |
| Independent Director | 3.3yrs | US$58.61k | 0.038% $ 6.8k |
3.7yrs
Average Tenure
65yo
Average Age
Experienced Board: HCWB's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 22:43 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HCW Biologics Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Okunewitch | Maxim Group |